Hottub News

Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer

3 reports from 3 outlets in 1 language · first reported · updated · JSON

HealthAkesocadonilimabnivolumabPR Newswirestomach cancer

Reports

  1. Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric CancerPublished by prnewswire.com, manilatimes.net, thailand-business-news.com ·

More in Health

  1. Russian researcher ‘dies of plague released by lab accident’60 outlets
  2. Doctors warn about the risks energy drinks pose to kids. What families need to know80 outlets
  3. Donna Manton: How ketamine therapy helped an ADF veteran heal | Bega District News45 outlets
  4. Russia hospitalizes almost 200 people after plague death: reports31 outlets
  5. 'Life-changing': mind-altering ketamine is helping veterans like Donna reclaim her life32 outlets
  6. Russian Researcher Dies Of Plague, Hundreds Quarantined, 5 Hospitals Shut24 outlets